Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
5,293,875
-
Share change
-
+5,224,438
-
Total reported value
-
$65,297,000
-
Price per share
-
$12.36
-
Number of holders
-
12
-
Value change
-
+$64,439,000
-
Number of buys
-
11
Institutional Holders of AMRYT PHARMA PLC - SPONSORED ADS (AMYT) as of Q3 2020
As of 30 Sep 2020,
AMRYT PHARMA PLC - SPONSORED ADS (AMYT) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,293,875 shares.
The largest 10 holders included
EdgePoint Investment Group Inc., Stonepine Capital Management, LLC, AMERIPRISE FINANCIAL INC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, ARMISTICE CAPITAL, LLC, Whitebox Advisors LLC, Global Frontier Investments LLC, Context Capital Management, LLC, Context Partners Fund, L.P., and UBS Group AG.
This page lists
12
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.